Under a MOU signed between both the parties, Merck and Siemens have decided to expand their cooperation in Smartfacturing.

--(BUSINESS WIRE)--MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, launched the ...

What’s next for Akeso and Summit Therapeutics after their cancer immunotherapy outperformed Merck’s Keytruda in a large Phase 3 clinical trial? Who’s the iconoclastic outsider behind Summit ...

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, today announced that the company ...

Merck (NYSE: MRK) is a top pharmaceutical company coming off a good quarter that shows it is growing its top and bottom lines. Even with that growth, the stock still trades at a fairly modest ...

PictorLabs, a pioneering software company transforming histopathology with AI-powered virtual staining, announced today the successful completion of its $30 million Series B funding round. The round ...

Merck and Siemens have signed a strategic partnership to accelerate digital transformation in manufacturing through smart, ...

MilliporeSigma is partnering with the Emmy® and Golden Globe® Award-winning ABC series “Abbott Elementary” to increase access ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Merck & Co.’s best-selling drug Keytruda helped women with a hard-to-treat form of breast cancer live longer, according to the first study to show such a benefit in these patients. After five ...

Avelumab is under clinical development by Merck and currently in Phase II for Cervical Cancer. According to GlobalData, Phase II drugs for Cervical Cancer have a 35% phase transition success rate ...